Group 1: Diageo - Diageo is known for brands like Guinness, Captain Morgan Rum, and Crown Royal Canadian Whiskey, and it pays a semiannual dividend with a yield of 4.4% based on recent payments [1][2] - The company pays out approximately 50% of its earnings as dividends, which is standard for its industry [2] - Analysts forecast an 18% increase in the annual dividend by 2029, with the stock currently trading at a discount of over 25% to its fair value estimate of $130 per ADR share [3] Group 2: GlaxoSmithKline (GSK) - GSK has historically paid out about 70% of normalized earnings as dividends, which has limited its ability to reinvest in R&D and acquisitions [4] - Following the divestment of its consumer group in 2022, GSK lowered its dividend to a more appropriate level, which is now considered secure and likely to grow in line with earnings over the next 5 years [4] - GSK's US ADR shares provide a quarterly payout of $0.32, translating to an annual dividend rate of $1.70 and a yield of 3.7%, with the stock trading at a 20% discount to fair value [5] Group 3: Kimberly-Clark - Kimberly-Clark is a leading manufacturer in the tissue and hygiene space, recognized as both a dividend aristocrat and a dividend king, having increased its annual dividend payout for 53 consecutive years [6] - The company announced a 3.3% dividend hike for 2025, consistent with its 5-year annualized dividend growth rate of 3.4% [6] - The stock currently yields 4.3%, slightly above its 5-year average, and the long-term outlook calls for mid-single-digit annual dividend growth [7]